Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines – Update

Link permanente della pagina
www.swissmedic.ch/out-of-stock-covid19-en

Status as of 20.01.2021

In Ordinance 3 on Measures to Combat the Coronavirus (Covid-19 Ordinance 3, SR 818.101.24), the Federal Council issues provisions designed to ensure the supply of important medical goods. Based on Art. 22 para. 3 of this ordinance, Swissmedic can approve the import of essentially identical medicinal products as a short-term solution for any temporary non-availability of medicinal products.

The following table lists the temporary import and distribution licences granted by Swissmedic on the basis of the Covid-19 Ordinance. The products may only be distributed to hospitals. The allocation of the goods and information provided on their respective availability is generally the responsibility of the department at the Federal Office of Public Health responsible for procuring medical goods.

Active substance Pharmaceutical form / Dosage Batch reference Distribution licensed until
Lopinavir / Ritonavir

Film-coated tablets, 200 mg/tab. and 50 mg/tab.

Syrup, 400 mg/5 ml and 100 mg/5 ml

1125683 / 1125601/ 1126558

6088208 / 6088549
31.12.2020
Erythromycin Powder for solution for infusion, 1 g 01124TB23 31.07.2020
Hydroxychloroquine Lactab, 200 mg IYZ019 001- IYZ019 007 31.12.2020
Atazanavir Capsules, 200 mg ABH6626 30.11.2020
Propofol Emulsion for injection/infusion, 10 mg/ml V19A013A / V19A013B / V19A013C 31.12.2020
Budesonide / Formoterol Powder for inhalation, 100 µg/6 µg SLGV 31.08.2020
Rocuronium Solution for injection 50 mg/5 ml T007003 31.12.2020
Propofol Emulsion for injection and infusion, 10 mg/ml 10PC9969 / 16PB6740 31.12.2020
Hydroxychloroquine Film-coated tablets, 200 mg JM2447 31.12.2020
Lopinavir / Ritonavir Tablets, 200 mg/50 mg E200320 31.12.2020
Sufentanil / Sufentanil citrate Solution for injection,
0.005 mg/ml and 0.05 mg/ml
MU9A (0.005mg/ml
5 x 2ml)
JG9W (0.005mg/ml
10 x 10ml)
HG2B (0.05mg/ml
10 x 5ml)
29.10.2021
Solution for haemodialysis and haemofiltration Sodium 140 mmol/l
Potassium 4 mmol/l
Magnesium 0.75 mmol/l
Chloride 122 mmol/l
Hydrogen phosphate 1 mmol/l
Hydrogen carbonate 22 mmol/l/ 1000 ml
19G0415
19K0610
 
30.06.2020
Sufentanil / Sufentanil citrate Solution for injection,
0.005 mg/ml
5 x 10 ml
Batch BG4 29.10.2021
Midazolam Ampoules, 50 mg/10 ml F1038F08 / F1048F02 31.12.2020
Posaconazole Gastro-resistant tablet, 100 mg T001796 and T001390 01.11.2020
Midazolam Ampoules, 50 mg/10 ml F1058F02 31.12.2020
Rocuronium Solution for injection 50 mg/5 ml T012764 31.01.2021
Budesonide / Formoterol Powder for inhalation, 100 µg/6 µg LATU 31.08.2020
Propofol Emulsion for infusion 2 % MCT 16PD7549 31.12.2021
Amoxicillin / Clavulanic acid 2g/200 mg, powder for preparation of a solution for injection or infusion KP0957 31.08.2020
Amoxicillin / Clavulanic acid 2g/200 mg, powder for preparation of a solution for injection or infusion KS3426
KS3427
30.10.2020
Amoxicillin / Clavulanic acid 2g/200 mg, powder for preparation of a solution for injection or infusion KS3429 30.11.2020
Propofol Emulsion for injection/infusion, 10 mg/ml 20K001A, 20K001B, 20K002A, 20K002B, 20K003A, 20K003B 31.08.2021
Voriconazol Powder for preparation of a solution for infusion, 200mg 6452099 30.06.2021
Remdesivir Powder for preparation of a solution for infusion, 100mg C2000141D2,
20410871D1
00009D
00009D4
00010D2
20411011M
AP0083BM1
AP0425BM1
29.10.2021
Haemagglutininum influenzae A (H1N1) (H3N2)
Haemagglutininum influenzae B (Victoria) (Yamagata)
Suspension for injection X47 30.06.2021
Haemagglutininum influenzae A (H1N1)
Haemagglutininum influenzae A (H3N2)
Haemagglutininum influenzae B
Suspension for injection 7132B1A 30.04.2021
Propofol Emulsion for injection K20001A
K20005A
K20005B
31.12.2022
Remifentanil

Powder for preparation of a solution for infusion

1mg

5mg

 

 

50PDH010

50PEH013

30.04.2022
Propofol 20 mg/ml (50 ml emulsion for injection in a pre-filled syringe) RM659 31.12.2021

Medicinal products imported by hospital pharmacists under their own responsibility according to Art. 22 para. 1 of the Covid-19 Ordinance 3 are not included in this list.

Last modification 20.01.2021

Top of page